Magnesium, which is necessary for more than 300 biochemical reactions in the body, has been the focus of interest in the brain health sector. The charge into the brain health realm is being led by the magnesium L-threonate ingredient branded Magtein by Magceutics. The ingredient is distributed by AIDP.
Kathy Lund, VP of business development & marketing for AIDP, told us that magnesium L-threonate was discovered by MIT professors searching for novel neurodegenerative disease treatments.
“For this reason, Magtein was extensively studied in cell culture, in animal studies for its mechanisms of action, its effects on brain function, as well as its safety,” she told us. “These results are published in prestigious neurological journals, including Neuron, and supported by top neurological scientists in the world, including Nobel Prize winners.
“One reason Magtein has generated so much interest from consumers is its mechanism of action: it restores the neural cells to their healthy, youthful conditions by blocking background signal activation, while many other brain ingredients/drugs continue stimulating cells. Recently, a human clinical study using Magtein was performed and preliminary results indicate a significant improvement in memory and cognition.”
Products containing the ingredient have reported strong repeat and excellent consumer acceptance, she added, with survey data claimed to show that over 90% of consumers using Magtein would recommend the product, primarily because they experienced a positive effect.
“Magnesium l-threonate naturally exists in our body and brain. Magtein is an ideal supplement to restore our brain and body’s magnesium levels to prevent neural degeneration and restore brain function.”